Stool-based screening for colorectal cancer may be sharper in women than in men, and the reason traces back to sex-specific ...

One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

Colorectal cancer is now the leading cause of cancer-related death among adults under 50 in the United States, and diagnoses in younger adults continue to increase at an alarming rate. In fact, it has ...

Bernstein lifted its Guardant Health price target to $200 after UnitedHealth's Shield coverage decision. Here's what it means ...

Colon cancer is now the number one cancer killer in the U.S. of people ages 50 and younger, and yet many folks (at any age) ...

When Erica Barnell was an MD/PhD student at Washington University in St. Louis, she met a woman who had stage four colorectal cancer (CRC). The woman was only 52 years old—more than a decade younger ...

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

Ontario has lowered the eligibility age for colon cancer screening from 50 to 45, a move that cancer survivor Ashley Wiley ...